Alembic Pharmaceuticals informs about updates

13 Mar 2023 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has successfully completed the United States Food and Drug Administration (USFDA) inspection for its Derma Facility located at Karakhadi without any observations. The inspection was conducted from 6th March, 2023 to 10th March, 2023.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

838.70 -13.60 (-1.60%)
29-Dec-2025 14:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1715.60
Dr. Reddys Lab 1266.25
Cipla 1494.00
Zydus Lifesciences 904.50
Lupin 2081.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×